Literature DB >> 25873808

Restoration of renal allograft function via reduced-contrast percutaneous revascularization of transplant renal artery stenosis.

Phillip A Erwin, Sachin S Goel, Surafel Gebreselassie, Mehdi H Shishehbor.   

Abstract

Transplant renal artery stenosis (TRAS), the most common vascular complication of kidney transplantation, can lead to heart failure, uncontrolled hypertension, and irreversible dysfunction of the transplanted kidney. Percutaneous revascularization can improve outcomes in well-selected patients with symptomatic TRAS, but the intervention itself poses risk to the transplanted kidney because of the quantities of nephrotoxic contrast solution that often are used. We report the case of a patient with TRAS who, 5 months after undergoing a kidney transplant, developed allograft dysfunction and heart failure that required hemodialysis. We performed angioplasty and stenting of the TRAS, using intravascular ultrasonography and fluoroscopy as our primary imaging methods. To minimize further damage to a potentially viable kidney, the volume of intravascular contrast medium used was trivial (a total of 9 cc). Revascularization of the patient's TRAS restored his renal function: within 4 weeks of the procedure, he no longer needed hemodialysis, and his heart failure symptoms had resolved. This case emphasizes the value of early definitive treatment of TRAS and the usefulness of intravascular ultrasonography to minimize the amount of contrast medium used in endovascular procedures.

Entities:  

Keywords:  Acute kidney injury; contrast media/adverse effects; kidney transplantation; kidney/blood supply; postoperative complications; renal artery obstruction/etiology/therapy; renal artery/ultrasonography; stents; ultrasonography, Doppler

Mesh:

Substances:

Year:  2015        PMID: 25873808      PMCID: PMC4378054          DOI: 10.14503/THIJ-13-4059

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  15 in total

Review 1.  Transplant renal artery stenosis.

Authors:  Simona Bruno; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

2.  The renal arterial resistance index and renal allograft survival.

Authors:  Jörg Radermacher; Michael Mengel; Sebastian Ellis; Stephan Stuht; Markus Hiss; Anke Schwarz; Ute Eisenberger; Michael Burg; Friedrich C Luft; Wilfried Gwinner; Hermann Haller
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

3.  Intravascular ultrasound-guided percutaneous coronary interventions with minimum contrast volume for prevention of the radiocontrast-induced nephropathy: report of two cases.

Authors:  Nobuhiko Ogata; Takashi Matsukage; Eri Toda; Seiji Tamiya; Toshiharu Fujii; Gaku Nakazawa; Naoki Masuda; Yoshihiro Morino; Yuji Ikari
Journal:  Cardiovasc Interv Ther       Date:  2010-11-06

4.  Renal arterial stenosis in renal allografts: retrospective study of predisposing factors and outcome after percutaneous transluminal angioplasty.

Authors:  N H Patel; R M Jindal; T Wilkin; S Rose; M S Johnson; H Shah; J Namyslowski; K P Moresco; S O Trerotola
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

5.  Intravascular ultrasound-guided renal artery stenting.

Authors:  G Dangas; J R Laird; R Mehran; A J Lansky; G S Mintz; M B Leon
Journal:  J Endovasc Ther       Date:  2001-06       Impact factor: 3.487

6.  Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis.

Authors:  J Radermacher; A Chavan; J Bleck; A Vitzthum; B Stoess; M J Gebel; M Galanski; K M Koch; H Haller
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

7.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Authors:  Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

8.  Percutaneous transluminal angioplasty as first-line treatment of transplant renal artery stenosis.

Authors:  B F Henning; S Kuchlbauer; C A Böger; A Obed; S Farkas; C Zülke; M N Scherer; M Scherer; A Walberer; M Banas; B Krüger; H J Schlitt; B Banas; B K Krämer
Journal:  Clin Nephrol       Date:  2009-05       Impact factor: 0.975

9.  Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years.

Authors:  Markus Zähringer; Marc Sapoval; Peter M T Pattynama; Claudio Rabbia; Claudio Vignali; Geert Maleux; Louis Boyer; Malgorzata Szczerbo-Trojanowska; Werner Jaschke; Geir Hafsahl; Mark Downes; Jean-Paul Bérégi; Nic J G M Veeger; Hans-Peter Stoll; Aly Talen
Journal:  J Endovasc Ther       Date:  2007-08       Impact factor: 3.487

10.  Transluminal angioplasty of transplanted renal artery stenosis: a review of the literature for its safety and efficacy.

Authors:  Polytimi Leonardou; Sofia Gioldasi; Paris Pappas
Journal:  J Transplant       Date:  2011-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.